Table I.
Sample Characteristics
| No. (%) Pts | |
|---|---|
| Sex | |
| Male | 20 (87.0%) |
| Female | 3 (13.0%) |
| Age | |
| Median (range) | 61 (40–76) |
| Race/ethnicity | |
| White | 18 (78.3%) |
| Hispanic | 3 (13.0%) |
| Black | 2 (8.7%) |
| Smoking status | |
| Never | 2 (8.7%) |
| Former | 16 (69.6%) |
| Current | 5 (21.7%) |
| Smoke after radiotherapy/chemoradiotherapy | |
| No | 16 (69.6%) |
| Yes | 7 (30.4%) |
| Site of primary HNC | |
| Larynx | 9 (39.1%) |
| Oropharynx | 7 (30.4%) |
| Hypopharynx | 3 (13.0%) |
| Unknown primary | 3 (13.0%) |
| Thyroid | 1 (4.4%) |
| Prior HNC treatment | |
| Radiotherapy | 8 (34.8%) |
| Chemoradiotherapy | 9 (39.1%) |
| Surgery → RT/CRT | 2 (9.0%) |
| RT/CRT → salvage conservation surgery | 4 (17.4%) |
| Location of radiotherapy | |
| MDACC | 11 (47.8%) |
| Outside facility | 12 (52.1%) |
| Extent surgery (for dysfunction) | |
| TL | 14 (60.9%) |
| TL + partial pharyngectomy | 6 (26.1%) |
| TLP | 3 (13.0%) |
| Tracheoesophageal puncture | |
| None | 7 (30.4%) |
| Primary | 8 (34.8%) |
| Secondary | 8 (34.8%) |
| Time post last HNC treatment | |
| Median yrs (range) | 2 (0.1–23) |
| >5 yrs posttreatment | 7 (30.4%) |
| >10 yrs posttreatment | 5 (21.7%) |
| Total sample | 23 |
Abbreviations: HNC, head and neck cancer, RT, radiotherapy, CRT, chemoradiotherapy, MDACC, The University of Texas MD Anderson Cancer Center, TL, total laryngectomy, TLP, total laryngopharyngectomy